Tirzepatide
IncretinApproved for other indicationstirz · Mounjaro · Zepbound
A dual GIP/GLP-1 agonist. Weekly titration is the usual protocol shape. Pens are fixed-dose; compounded vials need a locked concentration.
- Typical form
- Prefilled pen
- Typical route
- Subcutaneous
- Display unit
- mg
- Typical vial
- 10 mg
- Half-life (approx.)
- 120 h
- Default in-use window
- 56 days
Labeled / commonly logged
Typical protocol
A snapshot of how this compound is logged — not a prescription. You set every number.
- Common range
- 2.5–15 mg
- Starting log
- 2.5 mg
- Cadence
- Titration ladder
- Timing
- Once weekly, same day each week
- Duration
- Labeled titration over months; do not skip steps
Branded pens: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly. Lock mg/mL from the vial or pen label. STRAND will not auto-escalate.
- Weeks 1–42.5 mg
- Weeks 5–85 mg
- Weeks 9–127.5 mg
- Weeks 13–1610 mg
- Weeks 17–2012.5 mg
- Weeks 21–5215 mg
Reconstitution note
Require mg/mL from the vial label before any draw is computed.
Storage
Label-driven for pens. Fridge for compounded multi-dose vials.
Cautions
Same unit-confusion risk as semaglutide. Do not auto-escalate a ladder.
Evidence posture
Approved branded products exist. Research/compounded vials are unreviewed.